IMO any pharma/biotech is just a huge bet; counting on “what’s in the pipeline” to become reality is such a bad probability (sheer nature of the industry) gamble.
I dont buy hopes and dreams, especially not against the odds when I invest. When I speculate its another deal, but we arent talking about speculation, are we?
If its just fun money there is no point in overthinking. Just put it in IDIA if you think its a good speculation. There is no point in taking a speculation serious and asking others about their opinion, because it is a speculation and not an investment. I personally wouldnt buy it, not at this point.
Maybe I should have picked a different title. I rather meant to “mimick” the (surprisingly popular) thread about Tesla and start a discussion that I personally find interesting. I had no intention to ask the forum whether I should really stash money or not in Idorsia.
Same thing with my other question about how capital increases are conducted. After some reading I discovered that it is indeed uncommon but not impossible to conduct capital increases without setting a grant price in advance. I asked the question out of an “academic” interest as I had never seen anything like it.
With a different titel you wouldnt have triggered @dbu
Since this is mainly an amateur forum and you have no clue who is sitting behind the screen there is a room for misinterpretation
Btw my comments werent meant as tell off
I recommend to look up the info if it is something technical, that hasnt much to do with personal experience, but for further clarification how I mean this statement check out the Degiro/SQ thread.
Buy as a purely speculative gamble.
Or if you have a really, really good idea about their products - that is, if you believe you can predict potential and risks of the company’s products (and pipeline) better than the average financial analyst (at least).
Like dbu said, I also believe research-oriented pharma/biotech is one of the, possibly the hardest sector to do stock-picking in, due to the nature of product safety, clinical testing and regulatory affairs, which are highly unpredictable. Especially for outsiders.
It’s much, much easier for virtually any other sector, as a non-specialist/without serious sector experience.
1 Like
By reading and partipating to this forum, you confirm you have read and agree with the disclaimer presented on http://www.mustachianpost.com/
Durch das Lesen und die Teilnahme an diesem Forum bestätigst du, dass du den auf http://www.mustachianpost.com/de/ dargestellten Haftungsausschluss gelesen hast und damit einverstanden bist.